ETF Holdings Breakdown of QURE

QURE institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-09-26	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	21,546	USD 1,170,163
2025-09-26	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	7,002	USD 380,279
2025-09-26	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	30,566	USD 1,660,039
2025-09-26	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	30,566	USD 1,660,039
Total =		89,680	USD 4,870,520

Book value of shares is calculated on the adjusted close price of each day (row).

News associated with QURE

uniQure (NASDAQ:QURE) Receives “Buy” Rating from Chardan Capital

Chardan Capital reaffirmed their buy rating on shares of uniQure (NASDAQ:QURE – Free Report) in a research report sent to investors on Monday morning,Benzinga reports. They currently have a $35.00 target price on the biotechnology company’s stock. Several other research analysts also recently commented on QURE. Wall Street Zen raised uniQure from a “sell” rating […] - 2025-09-09 03:10:46

uniQure (NASDAQ:QURE) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of uniQure (NASDAQ:QURE – Free Report) from a sell rating to a hold rating in a report issued on Saturday morning. QURE has been the subject of several other research reports. Guggenheim reiterated a “buy” rating and issued a $28.00 price objective on shares of uniQure in a research note […] - 2025-08-05 03:00:52

uniQure N.V. (NASDAQ:QURE) Receives $37.82 Average Target Price from Analysts

uniQure N.V. (NASDAQ:QURE – Get Free Report) has earned a consensus rating of “Moderate Buy” from the eleven brokerages that are currently covering the stock, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation, six have given a buy recommendation and two have assigned a strong buy recommendation to the company. […] - 2025-07-31 03:13:08

uniQure (NASDAQ:QURE) Share Price Crosses Below Fifty Day Moving Average Following Insider Selling

Shares of uniQure N.V. (NASDAQ:QURE – Get Free Report) crossed below its fifty day moving average during trading on Monday after an insider sold shares in the company. The stock has a fifty day moving average of $14.29 and traded as low as $13.65. uniQure shares last traded at $13.95, with a volume of 1,978,275 […] - 2025-06-24 02:20:53

uniQure (NASDAQ:QURE) Shares Acquired by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. boosted its holdings in uniQure (NASDAQ:QURE – Free Report) by 355.2% during the first quarter, HoldingsChannel reports. The fund owned 334,894 shares of the biotechnology company’s stock after buying an additional 261,323 shares during the period. Assenagon Asset Management S.A.’s holdings in uniQure were worth $3,550,000 at the end of the […] - 2025-06-16 05:08:54

uniQure (NASDAQ:QURE) Receives $37.82 Average Price Target from Analysts

uniQure (NASDAQ:QURE – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the eleven brokerages that are currently covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold rating, six have issued a buy rating and two have given a strong buy rating to the […] - 2025-06-11 04:20:59

Bank of America Corp DE Sells 182,421 Shares of uniQure (NASDAQ:QURE)

Bank of America Corp DE cut its holdings in uniQure (NASDAQ:QURE – Free Report) by 72.5% in the 4th quarter, HoldingsChannel.com reports. The fund owned 69,064 shares of the biotechnology company’s stock after selling 182,421 shares during the period. Bank of America Corp DE’s holdings in uniQure were worth $1,220,000 as of its most recent […] - 2025-06-06 04:37:00

Stock Traders Buy Large Volume of uniQure Call Options (NASDAQ:QURE)

uniQure (NASDAQ:QURE – Get Free Report) was the recipient of some unusual options trading on Tuesday. Investors bought 8,961 call options on the company. This is an increase of 314% compared to the average volume of 2,162 call options. Institutional Inflows and Outflows Several hedge funds and other institutional investors have recently bought and sold […] - 2025-06-05 02:26:44

uniQure Sees Unusually High Options Volume (NASDAQ:QURE)

uniQure (NASDAQ:QURE – Get Free Report) saw unusually large options trading on Wednesday. Stock traders acquired 3,615 put options on the company. This is an increase of approximately 102% compared to the average volume of 1,792 put options. Analysts Set New Price Targets QURE has been the topic of a number of research analyst reports. […] - 2025-05-23 02:01:04

uniQure (NASDAQ:QURE) Upgraded at Cantor Fitzgerald

Cantor Fitzgerald upgraded shares of uniQure (NASDAQ:QURE – Free Report) to a strong-buy rating in a research note issued to investors on Monday,Zacks.com reports. Cantor Fitzgerald also issued estimates for uniQure’s FY2025 earnings at ($2.76) EPS. Several other research analysts have also recently commented on QURE. HC Wainwright restated a “buy” rating and issued a […] - 2025-05-22 04:50:48

Ameriprise Financial Inc. Sells 333,968 Shares of uniQure (NASDAQ:QURE)

Ameriprise Financial Inc. decreased its holdings in shares of uniQure (NASDAQ:QURE – Free Report) by 38.6% in the fourth quarter, Holdings Channel reports. The firm owned 531,830 shares of the biotechnology company’s stock after selling 333,968 shares during the quarter. Ameriprise Financial Inc.’s holdings in uniQure were worth $9,392,000 at the end of the most […] - 2025-05-21 04:26:50

Chardan Capital Reaffirms “Buy” Rating for uniQure (NASDAQ:QURE)

uniQure (NASDAQ:QURE – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities research analysts at Chardan Capital in a report released on Monday,Benzinga reports. They currently have a $38.00 price objective on the biotechnology company’s stock. Chardan Capital’s price target points to a potential upside of 196.64% from the stock’s previous close. QURE […] - 2025-05-14 02:56:49

uniQure (NASDAQ:QURE) Earns Buy Rating from Guggenheim

uniQure (NASDAQ:QURE – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at Guggenheim in a note issued to investors on Monday,Benzinga reports. They currently have a $28.00 price target on the biotechnology company’s stock. Guggenheim’s price objective suggests a potential upside of 118.58% from the stock’s current price. A number of […] - 2025-05-14 02:56:48

uniQure (NASDAQ:QURE) Position Lowered by Stifel Financial Corp

Stifel Financial Corp reduced its position in uniQure (NASDAQ:QURE – Free Report) by 7.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 56,168 shares of the biotechnology company’s stock after selling 4,828 shares during the quarter. Stifel Financial Corp’s […] - 2025-05-09 05:28:58

uniQure (NASDAQ:QURE) Short Interest Up 19.8% in April

uniQure (NASDAQ:QURE – Get Free Report) was the recipient of a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 5,260,000 shares, a growth of 19.8% from the March 31st total of 4,390,000 shares. Based on an average daily trading volume, of 1,380,000 shares, the […] - 2025-05-05 04:58:48

uniQure (NASDAQ:QURE) Earns “Buy” Rating from HC Wainwright

uniQure (NASDAQ:QURE – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at HC Wainwright in a research report issued to clients and investors on Monday,Benzinga reports. They presently have a $70.00 target price on the biotechnology company’s stock. HC Wainwright’s target price would indicate a potential upside of 386.45% from […] - 2025-04-23 02:34:42

Pre-Market Most Active for Apr 17, 2025 : HTZ, TSLL, NVDA, TQQQ, SQQQ, QURE, TSM, HIMS, NVO, UNH, BABA, NIO

The NASDAQ 100 Pre-Market Indicator is up 152.15 to 18,409.79. The total Pre-Market volume is currently 187,788,799 shares traded.The following are the most active stocks for the pre-market session: Hertz Global Holdings, Inc (HTZ) is +1.35 at $7.06, with 12,622,622 shares trade - 2025-04-17 09:28:52

Alliancebernstein L.P. Increases Stock Position in uniQure (NASDAQ:QURE)

Alliancebernstein L.P. boosted its holdings in uniQure (NASDAQ:QURE – Free Report) by 14.2% in the fourth quarter, Holdings Channel reports. The institutional investor owned 203,919 shares of the biotechnology company’s stock after acquiring an additional 25,319 shares during the quarter. Alliancebernstein L.P.’s holdings in uniQure were worth $3,601,000 as of its most recent filing with […] - 2025-04-15 04:50:49

uniQure (NASDAQ:QURE) Coverage Initiated at Chardan Capital

Equities researchers at Chardan Capital initiated coverage on shares of uniQure (NASDAQ:QURE – Get Free Report) in a note issued to investors on Tuesday, Marketbeat Ratings reports. The brokerage set a “buy” rating and a $38.00 price target on the biotechnology company’s stock. Chardan Capital’s price target points to a potential upside of 257.82% from […] - 2025-04-03 04:26:59

Analysts Set uniQure (NASDAQ:QURE) PT at $38.89

Shares of uniQure (NASDAQ:QURE – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the ten ratings firms that are covering the firm, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation, six have issued a buy recommendation and one has issued a strong buy recommendation on the […] - 2025-03-28 04:56:46

uniQure (NASDAQ:QURE) Rating Increased to Sell at StockNews.com

uniQure (NASDAQ:QURE – Get Free Report) was upgraded by equities research analysts at StockNews.com to a “sell” rating in a research report issued to clients and investors on Tuesday. QURE has been the subject of a number of other research reports. Cantor Fitzgerald lifted their target price on shares of uniQure from $28.00 to $58.00 […] - 2025-03-13 04:26:52

uniQure (NASDAQ:QURE) Receives Buy Rating from HC Wainwright

uniQure (NASDAQ:QURE – Get Free Report)‘s stock had its “buy” rating reaffirmed by HC Wainwright in a research note issued on Tuesday,Benzinga reports. They presently have a $70.00 price target on the biotechnology company’s stock. HC Wainwright’s target price would indicate a potential upside of 478.99% from the stock’s previous close. Several other equities research […] - 2025-03-06 06:56:12

William Blair Predicts uniQure’s Q1 Earnings (NASDAQ:QURE)

uniQure (NASDAQ:QURE – Free Report) – William Blair decreased their Q1 2025 earnings per share (EPS) estimates for shares of uniQure in a report released on Thursday, February 27th. William Blair analyst S. Corwin now anticipates that the biotechnology company will post earnings of ($1.48) per share for the quarter, down from their prior forecast […] - 2025-03-04 04:33:08

Y Intercept Hong Kong Ltd Lowers Stake in uniQure (NASDAQ:QURE)

Y Intercept Hong Kong Ltd lowered its stake in shares of uniQure (NASDAQ:QURE – Free Report) by 50.6% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 28,319 shares of the biotechnology company’s stock after selling 29,014 shares during the period. Y Intercept Hong Kong Ltd owned […] - 2025-03-03 06:28:55

uniQure (NASDAQ:QURE) Receives $40.00 Average Price Target from Analysts

Shares of uniQure (NASDAQ:QURE – Get Free Report) have received a consensus rating of “Buy” from the ten ratings firms that are presently covering the company, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating, six have assigned a buy rating and two have issued a strong buy rating on the […] - 2025-02-06 05:00:57

Back to Listing

Disclaimer